Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(1.83)
# 2,992
Out of 4,784 analysts
360
Total ratings
28.33%
Success rate
-9.57%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MIST Milestone Pharmaceuticals | Reiterates: Buy | $25 | $0.88 | +2,740.91% | 18 | Mar 28, 2025 | |
| DTIL Precision BioSciences | Reiterates: Buy | $60 | $4.70 | +1,176.60% | 17 | Mar 28, 2025 | |
| IVVD Invivyd | Reiterates: Buy | $10 | $0.60 | +1,566.67% | 17 | Mar 26, 2025 | |
| ATAI Atai Life Sciences | Reiterates: Buy | $10 | $1.47 | +580.27% | 18 | Mar 19, 2025 | |
| GOSS Gossamer Bio | Reiterates: Buy | $10 | $1.17 | +754.70% | 16 | Mar 18, 2025 | |
| ALT Altimmune | Reiterates: Buy | $12 | $5.32 | +125.56% | 16 | Mar 18, 2025 | |
| VYGR Voyager Therapeutics | Reiterates: Buy | $30 | $3.65 | +721.92% | 9 | Mar 13, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $29.58 | +238.07% | 20 | Mar 12, 2025 | |
| ONCY Oncolytics Biotech | Reiterates: Buy | $5 | $0.60 | +733.33% | 17 | Mar 10, 2025 | |
| BEAM Beam Therapeutics | Reiterates: Buy | $80 | $22.21 | +260.20% | 7 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $6.19 | +788.53% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $3.44 | +2,080.23% | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $2.94 | +1,430.61% | 14 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $12.47 | +461.35% | 13 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $6.70 | +1,541.79% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $75 → $70 | $33.19 | +110.91% | 5 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $400 → $500 | $268.46 | +86.25% | 25 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $36.50 | +132.88% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $150 | $6.72 | +2,132.14% | 17 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $13.82 | +478.87% | 22 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $11.06 | +261.66% | 14 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.82 | +1,119.51% | 24 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $13.43 | +406.33% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $230 → $20 | $0.23 | +8,591.87% | 2 | Dec 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $247.01 | +37.65% | 1 | Aug 18, 2021 | |
Milestone Pharmaceuticals
Mar 28, 2025
Reiterates: Buy
Price Target: $25
Current: $0.88
Upside: +2,740.91%
Precision BioSciences
Mar 28, 2025
Reiterates: Buy
Price Target: $60
Current: $4.70
Upside: +1,176.60%
Invivyd
Mar 26, 2025
Reiterates: Buy
Price Target: $10
Current: $0.60
Upside: +1,566.67%
Atai Life Sciences
Mar 19, 2025
Reiterates: Buy
Price Target: $10
Current: $1.47
Upside: +580.27%
Gossamer Bio
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $1.17
Upside: +754.70%
Altimmune
Mar 18, 2025
Reiterates: Buy
Price Target: $12
Current: $5.32
Upside: +125.56%
Voyager Therapeutics
Mar 13, 2025
Reiterates: Buy
Price Target: $30
Current: $3.65
Upside: +721.92%
Immunocore Holdings
Mar 12, 2025
Reiterates: Buy
Price Target: $100
Current: $29.58
Upside: +238.07%
Oncolytics Biotech
Mar 10, 2025
Reiterates: Buy
Price Target: $5
Current: $0.60
Upside: +733.33%
Beam Therapeutics
Mar 10, 2025
Reiterates: Buy
Price Target: $80
Current: $22.21
Upside: +260.20%
Mar 7, 2025
Reiterates: Buy
Price Target: $55
Current: $6.19
Upside: +788.53%
Mar 7, 2025
Reiterates: Buy
Price Target: $75
Current: $3.44
Upside: +2,080.23%
Mar 4, 2025
Reiterates: Buy
Price Target: $45
Current: $2.94
Upside: +1,430.61%
Mar 4, 2025
Reiterates: Buy
Price Target: $70
Current: $12.47
Upside: +461.35%
Feb 28, 2025
Reiterates: Buy
Price Target: $110
Current: $6.70
Upside: +1,541.79%
Feb 27, 2025
Maintains: Buy
Price Target: $75 → $70
Current: $33.19
Upside: +110.91%
Feb 25, 2025
Reiterates: Buy
Price Target: $400 → $500
Current: $268.46
Upside: +86.25%
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $36.50
Upside: +132.88%
Feb 13, 2025
Maintains: Buy
Price Target: $190 → $150
Current: $6.72
Upside: +2,132.14%
Feb 12, 2025
Reiterates: Buy
Price Target: $80
Current: $13.82
Upside: +478.87%
Jan 27, 2025
Reiterates: Buy
Price Target: $40
Current: $11.06
Upside: +261.66%
Jan 27, 2025
Reiterates: Buy
Price Target: $10
Current: $0.82
Upside: +1,119.51%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $13.43
Upside: +406.33%
Dec 28, 2021
Maintains: Buy
Price Target: $230 → $20
Current: $0.23
Upside: +8,591.87%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $247.01
Upside: +37.65%